Immunic, Inc. Other Comprehensive Income (Loss), Net of Tax
Immunic, Inc. (IMUX) reported Other Comprehensive Income (Loss), Net of Tax of -$77.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2024-05-08
- Immunic, Inc. other comprehensive income (loss), net of tax for the quarter ending 2023-09-30 was -$77.00K, a 128.10% decline year-over-year.
- Immunic, Inc. other comprehensive income (loss), net of tax for the quarter ending 2023-06-30 was $171.00K.
- Immunic, Inc. other comprehensive income (loss), net of tax for the quarter ending 2023-03-31 was $776.00K.
- Immunic, Inc. other comprehensive income (loss), net of tax for the quarter ending 2022-09-30 was $274.00K, a 54.18% decline year-over-year.
- Immunic, Inc. other comprehensive income (loss), net of tax for fiscal 2022 was $3.29M, a 14.84% decline from fiscal 2021.
- Immunic, Inc. other comprehensive income (loss), net of tax for fiscal 2021 was $3.86M.
- Immunic, Inc. other comprehensive income (loss), net of tax for fiscal 2020 was -$2.74M.
- Immunic, Inc. other comprehensive income (loss), net of tax for fiscal 2019 was -$554.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month | Other Comprehensive Income (Loss), Net of Tax 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-09-30 | -$77.00K 10-Q · filed 2023-11-14 | $94.00K derived: sum of 2 quarters · filed 2023-11-14 | $870.00K derived: sum of 3 quarters · filed 2024-05-08 | |||
| 2023-06-30 | $171.00K 10-Q · filed 2023-11-14 | $947.00K derived: sum of 2 quarters · filed 2024-05-08 | ||||
| 2023-03-31 | $776.00K 10-Q · filed 2024-05-08 | |||||
| 2022-12-31 | $3.29M 10-K · filed 2023-02-23 | |||||
| 2022-09-30 | $274.00K 10-Q · filed 2023-11-14 | -$76.00K derived: sum of 2 quarters · filed 2023-11-14 | -$134.00K derived: sum of 3 quarters · filed 2023-11-14 | |||
| 2022-06-30 | -$350.00K 10-Q · filed 2023-11-14 | -$408.00K derived: sum of 2 quarters · filed 2023-11-14 | ||||
| 2022-03-31 | -$58.00K 10-Q · filed 2023-11-14 | |||||
| 2021-12-31 | $3.86M 10-K · filed 2023-02-23 | |||||
| 2021-09-30 | $598.00K 10-Q · filed 2022-11-03 | $321.00K derived: sum of 2 quarters · filed 2022-11-03 | $3.31M derived: sum of 3 quarters · filed 2022-11-03 | |||
| 2021-06-30 | -$277.00K 10-Q · filed 2022-11-03 | $2.71M derived: sum of 2 quarters · filed 2022-11-03 | ||||
| 2021-03-31 | $2.99M 10-Q · filed 2022-11-03 | |||||
| 2020-12-31 | -$2.74M 10-K · filed 2021-02-26 | |||||
| 2020-09-30 | -$144.00K 10-Q · filed 2021-11-04 | -$70.00K derived: sum of 2 quarters · filed 2021-11-04 | -$379.00K derived: sum of 3 quarters · filed 2021-11-04 | $52.00K derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | $74.00K 10-Q · filed 2021-11-04 | -$235.00K derived: sum of 2 quarters · filed 2021-11-04 | $196.00K derived: sum of 3 quarters · filed 2021-11-04 | -$886.00K derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-03-31 | -$309.00K 10-Q · filed 2021-11-04 | $122.00K derived: sum of 2 quarters · filed 2021-11-04 | -$960.00K derived: sum of 3 quarters · filed 2021-11-04 | -$616.00K derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2019-12-31 | $431.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$651.00K derived: sum of 2 quarters · filed 2021-02-26 | -$307.00K derived: sum of 3 quarters · filed 2021-02-26 | -$554.00K 10-K · filed 2021-02-26 | ||
| 2019-09-30 | -$1.08M 10-Q · filed 2020-11-06 | -$738.00K derived: sum of 2 quarters · filed 2020-11-06 | -$985.00K 10-Q · filed 2019-11-07 | -$1.11M derived: sum of 4 quarters · filed 2020-11-06 | ||
| 2019-06-30 | $344.00K 10-Q · filed 2020-11-06 | $97.00K derived: sum of 2 quarters · filed 2020-11-06 | -$32.00K derived: sum of 3 quarters · filed 2020-11-06 | -$65.00K derived: sum of 4 quarters · filed 2020-11-06 | ||
| 2019-03-31 | -$247.00K 10-Q · filed 2020-11-06 | -$376.00K derived: sum of 2 quarters · filed 2020-11-06 | -$409.00K derived: sum of 3 quarters · filed 2020-11-06 | -$1.14M derived: sum of 4 quarters · filed 2020-11-06 | ||
| 2018-12-31 | -$129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$162.00K derived: sum of 2 quarters · filed 2020-03-16 | -$890.00K derived: sum of 3 quarters · filed 2020-03-16 | -$862.00K 10-K · filed 2020-03-16 | $2.00K 10-K · filed 2019-03-04 | |
| 2018-09-30 | -$33.00K 10-Q · filed 2019-11-07 | -$761.00K derived: sum of 2 quarters · filed 2019-11-07 | -$733.00K 10-Q · filed 2019-11-07 | |||
| 2018-06-30 | -$728.00K 10-Q · filed 2019-08-08 | -$700.00K derived: sum of 2 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $28.00K 10-Q · filed 2019-08-08 | -$3.00K 10-Q · filed 2019-04-10 | ||||
| 2017-12-31 | -$5.00K 10-K · filed 2019-03-04 | |||||
| 2016-12-31 | $3.00K 10-K · filed 2019-03-04 | |||||
| 2015-12-31 | -$9.00K 10-K · filed 2018-03-13 | |||||
| 2014-12-31 | -$7.00K 10-K · filed 2017-03-07 | |||||
| 2013-12-31 | $8.00K 10-K · filed 2016-03-08 | |||||
| 2012-12-31 | $5.00K 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |